The ICPO Theranostics Virtual Summit 2024 presented today's and tomorrow's clinical relevance of radiotheranostics in oncology
27.11.2024 09:00:00 CET | GlobeNewswire by notified | Press release
The world-class scientific program was provided by 35 international experts
November 27, 2024 – Wiesbaden, Germany. The International Centers for Precision Oncology Foundation (ICPO) hosted the ICPO Theranostics Virtual Summit 2024 on November 14 & 15, 2024, under the topic "A New Era of Alpha Emitters and Radiopharmaceuticals." The second edition of this virtual event, live streamed from a studio in Munich, brought together over 400 participants from 37 countries across Asia-Oceania, Africa, the Middle East, the Americas, and Europe. 35 experts and panelists explored for them the latest innovation in alpha emitters and new radiopharmaceuticals, such as FAP, CA9, CXCR4, and GPC3. These innovations show transformative potential in treating malignancies resistant to traditional therapies, offering hope for more effective and targeted treatment options for cancer patients worldwide, regardless of their geographic and social origins.
Opening the Summit, Udo J. Vetter, Chairman of the ICPO Board of Trustees, reflected on the ICPO Foundation's remarkable achievements to date and highlighted: "I express my heartfelt gratitude to the Summit Chairs Prof. Frederik L. Giesel, Director of the Department of Nuclear Medicine at the University Clinic Düsseldorf, Germany and Prof. Richard P. Baum, President of the ICPO Academy for Theranostics, as well as Odile Jaume, CEO of ICPO Foundation, for their exceptional efforts in curating a truly world-class program sketching together the contours of a new era in cancer care". Moreover, he stressed the excellent cooperation with the Scientific Advisory Board of the ICPO Summit 2024 composed of Frederik L. Giesel, Germany; Richard P. Baum, Germany; Cathy S. Cutler, USA; Ken Herrmann, Germany; Cristina Müller, Switzerland; Frank Rösch, Germany and Elcin Zan, USA.
The virtual event moderated by Odile Jaume, CEO of ICPO Foundation, and Susanne Simon, Head of Communications, started with a keynote by Prof. Steven M. Larson, emeritus member at Memorial Sloan Kettering Cancer Center in New York with his talk "History of Alpha Therapy". On the second day, Prof. Andrew M. Scott, Director at the Olivia Newton-John Cancer Research Institute, Australia, presented groundbreaking insights into FAP-targeted theranostics for oncology and fibrosis-related conditions with his talk on "History of FAP till today”.
Prof. Frederik L. Giesel, Chair of the ICPO Summit, summarized with much enthusiasm: "Bringing together experts and pioneers from around the globe, the Summit provided a unique platform for exchanging groundbreaking data and advancing research and clinical practice. It has been an honor to contribute to this exceptional event, which inspires progress and certainly shapes the future of theranostics".
Prof. Richard P. Baum, Co-Chair of the ICPO Summit, and President of the ICPO Academy for Theranostics and Chair of the ICPO Scientific Advisory Board, was deeply impressed by the speakers' presentations: "The ICPO Summit 2024 showcased an extraordinary lineup of renowned speakers, presenting some of the most cutting-edge innovations I have seen in the field. This Summit enabled incredible expertise to be shared amongst colleagues from all over the world. Furthermore, it will be of great benefit to all cancer patients."
Odile Jaume, CEO of ICPO Foundation, was delighted about the success of the ICPO Summit and the support it received: "My deep appreciation goes to all outstanding speakers who shared their expertise as well as to the sponsors and supporters who allowed to set an exceptional standard for the event. Their engagement and generosity have elevated the Summit and reinforced the ICPO Foundation's commitment to empowering the theranostics community worldwide."
Speakers and panelists of the ICPO Theranostics Summit 2024: Sanjana Ballal, Richard P. Baum, Hakim Bouterfa, Chris Bremer, David Cade, Dushen Chetty, Pedro Fragoso Costa, Cathy S. Cutler, Ebrahim Delpassand, Ward Digby, Marc Dweck, Germo Gericke, Jean-François Gestin, Frederik L. Giesel, Ken Herrmann, Michael Hofman, Anna Karmann, Steven M. Larson, Sze Ting Lee, Josh Mailman, Jacqueline Mock, Sherly Mosessian, Michael Nader, Jean-Pierre Pouget, Nick Pullen, Neil Quigley, Mike Sathekge, Serada Satoshi, Michael K. Schultz, Andrew M. Scott, Volker Wagner, Tadashi Watabe, Wolfgang Weber, Rudolf Werner, Elcin Zan.
Website of the ICPO Summit 2024: www.icpovirtualsummit.com; Link to Whitepaper Summit: www.icpo.foundation/icpo-forum-summit/
About ICPO Foundation
The International Centers for Precision Oncology Foundation (ICPO) is a non-profit organization established in 2019 under German law by leading international medical practitioners and life sciences entrepreneurs. Recognizing a paradigm shift in cancer care from one size fits all to a personalized approach, the ICPO Foundation is helping to build momentum to scale global patient access to Radiomolecular Precision Oncology to support this shift. Therefore, the ICPO Foundation aims to develop an international network of physical diagnostic and therapeutic centers for Precision Oncology organized in a Social Franchise model based on shared know-how, certified education with the “ICPO Academy for Theranostics,” and design and process standardization that enables best clinical practice globally. Furthermore, it is the ICPO Foundation's objective to empower its centers by embedding them in a highly inclusive community that spearheads its model and lives up to the Precision Oncology promise by making it available to all patients in need, irrespective of country or social status. Learn more about the ICPO Foundation at www.icpo.foundation and the ICPO Academy for Theranostics at www.theranostics.academy
Media contact ICPO Foundation: Susanne Simon, Head of Communication & Community
Email: susanne.simon@icpo.foundation, Phone: + 49 172 8666093, www.icpo.foundation
Attachments
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support investments in research, development and innovation11.6.2024 12:00:00 CEST | Press release
Turin, 11th June 2024. Iveco Group N.V. (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas, has successfully signed a term loan facility of 150 million euros with Cassa Depositi e Prestiti (CDP), for the creation of new projects in Italy dedicated to research, development and innovation. In detail, through the resources made available by CDP, Iveco Group will develop innovative technologies and architectures in the field of electric propulsion and further develop solutions for autonomous driving, digitalisation and vehicle connectivity aimed at increasing efficiency, safety, driving comfort and productivity. The financed investments, which will have a 5-year amortising profile, will be made by Iveco Group in Italy by the end of 2025. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a
DSV, 1115 - SHARE BUYBACK IN DSV A/S11.6.2024 11:22:17 CEST | Press release
Company Announcement No. 1115 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Trading dayNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-25478,1001,023.01489,100,86026:3 June 20247,0001,050.597,354,13027:4 June 20245,0001,055.705,278,50028:6 June20243,0001,096.273,288,81029:7 June 20244,0001,106.174,424,68
Landsbankinn hf.: Offering of covered bonds11.6.2024 11:16:36 CEST | Press release
Landsbankinn will offer covered bonds for sale via auction held on Thursday 13 June at 15:00. An inflation-linked series, LBANK CBI 30, will be offered for sale. In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 24 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99,594. Expected settlement date is 20 June 2024. Covered bonds issued by Landsbankinn are rated A+ with stable outlook by S&P Global Ratings. Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.
Relay42 unlocks customer intelligence with a new insights and reporting module, powered by Amazon QuickSight11.6.2024 11:00:00 CEST | Press release
AMSTERDAM, June 11, 2024 (GLOBE NEWSWIRE) -- Relay42, a leading European Customer Data Platform (CDP), is leveraging Amazon QuickSight to power its new real-time customer intelligence, reporting, and dashboard module. Harnessing the breadth and quality of customer data, the new Insights module empowers marketing teams to dive deep into customer behaviors and gain invaluable insights into the performance of their marketing programs across all online, offline, paid, and owned marketing channels. Preview of the Relay42 Insights module, in pre-beta version Key capabilities of the Relay42 Insights module include: Deep insights into customer behaviors: With the Relay42 Insights module, marketers can ask unlimited questions about their data and gain a deeper understanding of how to serve their customers more effectively. Simplicity with AI-powered querying: Marketers can use artificial intelligence to query their data using natural language search, reducing the reliance on data scientists. Us
Metasphere Labs Announces X Spaces Event on the Topic of Green Bitcoin Mining and Sound Money for Sustainability11.6.2024 10:30:00 CEST | Press release
VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere Labs" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is thrilled to announce an engaging Twitter Spaces event on Green Bitcoin mining, energy markets, and sustainability on July 3, 2024 at 2 p.m. ET. Follow us on X at MetasphereLabs for updates and to join the event. What We'll Discuss Bitcoin Mining Basics: Understand the fundamentals of Bitcoin mining.Energy Market Dynamics: Explore how Bitcoin mining interacts with energy markets.Sustainable Innovations: Learn about our efforts to promote sustainability in Bitcoin mining.Sound Money: Discover how tamper-proof currency can enhance stability.Efficient Payment Rails: See how fast, neutral payment systems support humanitarian projects.Carbon Footprint: Compare Bitcoin's environmental impact with traditional banking. "We're excited to host this event and dive into the critical topics of Bitcoin